Who owns TEVA PHARMACEUTICAL FIN NETH SR GLBL SUST 27?

Tip: Access positions for across all investors

Analyze quarterly positions in Teva Pharmaceutical Fin Neth Sr Glbl Sust 27 with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Teva Pharmaceutical Fin Neth Sr Glbl Sust 27 stock

Who bought or sold TEVA PHARMACEUTICAL FIN NETH SR GLBL SUST 27 this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Pacer Advisors 194k $188k 0% Mar 2024
 View chart